 | Conducted due diligence for a prospective acquirer of a business producing and selling pleural and peritoneal drainage catheters for palliative care of terminally ill patients in residential settings. |
| Carried out a due diligence investigation for a potential investor in a development-stage company marketing a new PACS/RIS combination product for radiological image management and practice administration. |
| For an investment bank seeking to evaluate a refinance proposal from the management team of a bioscience instrumentation firm active in the development, manufacture and sale of robotic systems, established the firm’s market position and assessed the value of the drug discovery segment of the firm’s business. |
| For a laboratory equipment supplier, conducted a due diligence investigation prior to the client’s acquisition of a private process-scale bioprocessing company, which was successfully concluded. |
| For a governmental business development agency, conducted three due diligence exercises on firms developing spinal, urinary and cochlear implants. |
| Assessed the technology, product positioning, and market potential of an emerging firm's two-photon fluorometry offerings as applied to microplate reading and microarray scanning for a major supplier of drug discovery tools. |
| As part of a comprehensive due diligence activity for a laboratory equipment supplier, assessed the product offerings and development portfolio of a target firm in the field of small-volume, automated liquid handling for life science research and drug discovery. |
| For a supplier of niche products used in orthopedic surgery, determined the technological and commercial positioning of resorbable products and technologies potentially useful in orthopedic fixation. |
| Conducted a due diligence investigation of an acquisition candidate, a private firm offering plating instruments for automated microbiology, for a producer of testing instruments for the food and dairy industries. |
| Assessed two established clinical diagnostics firms as potential investments for a Canadian business development agency. |
| For a seed-stage venture capital firm, assessed the likelihood of technical success of a project underway at an emerging technology firm working on a noninvasive glucose-sensing system for diabetics. |
| Established the applicability of a unique particle technology to biosensor implementation for an industrial materials manufacturer. |
| For a prospective investor, conducted a second round of due diligence on an early stage venture offering a range of innovative spinal implants, including an intervertebral fusion device. |
| Assessed a range of technologies applicable to the treatment of renal failure, including an implantable artificial kidney, for a trade association seeking to develop a U.S. market presence for an offshore producer. |
| For a laboratory equipment producer, conducted due diligence on a small firm marketing an innovative microplate reader based upon fluorescence polarization methods. |
| For an early stage venture with a proprietary new technology for pulsed-field gel electrophoresis for use in biotechnology research, assessed the technology’s business potential and evaluated a product concept before our client embarked upon detailed product development. |
| Conducted a due diligence investigation of the products, technologies and business model planned by a small, private company developing bipolar electrosurgery devices and trocars that was seeking equity financing from our client, a venture capital firm. |
©1998-2008 Trilogy Associates. All rights reserved.
Return to Home Page.